Ananda Developments - Ananda presenting at Master Investor Show
Announcement provided by
Ananda Pharma Plc · ANA26/02/2024 12:00
26 February 2024
ANANDA DEVELOPMENTS PLC
("Ananda" or the "Company")
Ananda presenting at Master Investor Show
Ananda Developments plc (AQSE: ANA), a company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of chronic, complex inflammatory pain conditions, is pleased to announce that certain Directors of the Company will be attending and speaking at the Master Investor Show in
The Company will be represented at the event by its CEO Melissa Sturgess and the Company's Finance director Jeremy Sturgess-Smith.
Ananda's CEO, Melissa Sturgess commented: "We look forward to meeting and talking with interested parties, shareholders, potential shareholders and stakeholders at the conference."
To register for the Master Investor Show, please use the following link: https://masterinvestorshow-2024.reg.buzz/?exhibitor-inviter=18f1c1fa-b9ee-11ee-9af7-000000000000
To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:
· Investor Hub: investors.anandadevelopments.com
· Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=
· LinkedIn: https://www.linkedin.com/company/anadevelopments/
· Twitter: https://twitter.com/AnandaPlc
· Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register-investor
-Ends-
The Directors of the Company accept responsibility for the contents of this announcement.
For more information please contact:
InvestorHub Engage with us directly at Ananda Developments Investor Hub
|
Sign up at investors.anandadevelopments.com |
ANANDA DEVELOPMENTS PLC Chief Executive Officer Melissa Sturgess
Jeremy Sturgess-Smith
|
+44 (0)7463 686 497 ir@anandadevelopments.com |
SP ANGEL CORPORATE FINANCE LLP Corporate Finance Richard Morrison Harry Davies-Ball |
+44 (0)20 3470 0470 |
Corporate Broking Abigail Wayne Rob Rees
|
|
Yellow Jersey PR Charles Goodwin Soraya Jackson |
+44 (0)20 3004 9512
|
About Ananda Developments
Ananda is an AQSE-listed company whose ambition is to be a leading provider of cannabinoid-based
medicines for the treatment of complex, chronic inflammatory pain conditions.
For further information on the Company visit https://anandadevelopments.com/ or sign up at https://investors.anandadevelopments.com/.
https://investors.anandadevelopments.com/link/0PQ09r
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.